Skip to main content Back to Top

ISMP Targeted Medication Safety Best Practices for Hospitals #16 - Minimize Risks Associated with the Use of Overrides with the Use of Automated Dispensing Cabinets (ADC)

Broadcast Date: September 9, 2021


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast explores the ISMP Best Practice #16 recommendations for minimizing risks associated with the use of overrides in Automated Dispensing Cabinets (ADC). The speakers discuss the pros and cons of use of overrides with ADCs and recommendations to safely implement and maintain this medication distribution process.


Kim MehtaKimberly Mehta serves as the Director of Medication Safety and Regulatory for the Allegheny Health Network.  As part of this position, Kim is responsible for regulatory compliance and implementation of USP standards throughout the health system.  Kim received her Doctor of Pharmacy from the University Of Pittsburgh School Of Pharmacy, Master of Public Health from Pitt, School of Public Health and her Master of Health Administration from Walden University.  She completed a combined PGY1/PGY2 Health System Pharmacy Administration Residency at Allegheny Health Network.   

Kim is an active member in local, state, and national organizations.  She is a current board member of the Pennsylvania Society of Health-System Pharmacists (PSHP) and chairs the PSHP Medication Safety Committee.  Kim has previously collaborated with the Virginia Department of Health, Northwest Virginia Regional Drug and Gang Task Force, and other local organizations to increase the role and engagement of pharmacists and support public health and safety initiatives focused in both Emergency Preparedness and combating the opioid epidemic. 

At a national level, Kim is an active member of American Society of Health System Pharmacists (ASHP), having served on several section advisory groups.  Kim is the 2020-21 Vice Chair of the Section Advisory Group on Medication Safety.  Through ASHP she has been involved with several national initiatives and groups including the USP 800 task force resulting in FAQ documents and creation of several national webinars on USP topics including assessment of risk and organizational implementation and challenges for USP 800.  Kim leads the Medication Safety Section Advisory Group Team on Medication Safety Dashboard creation and implementation.  Kim’s professional interests include patient safety and quality, sterile and non-sterile compounding, technology solutions, and healthcare reform.

Michael DejosDr. Michael Claro Dejos is the System Medication Safety Officer at Methodist Le Bonheur Healthcare in Memphis, TN. Mike is a member of the American Society of Health-System Pharmacists and is past chairman of the Medication Safety Advisory Group. He has served as an expert advisory member for the Institute for Safe Medication Practices for a number of resources and guidelines. His practice interests include system-level error reduction strategies, medication event detection, and change management.

Christina MichalekChristina Michalek, BS, RPh, FASHP is a Medication Safety Specialist and Administrative Coordinator for the Medication Safety Officers Society at the Institute for Safe Medication Practices. At ISMP, Chris works collaboratively consulting with health-system leaders and clinical staff to define, design, and improve medication safety initiatives. Chris also manages the update and analysis of ISMP’s Targeted Medication Safety Best Practices for Hospitals and is the ISMP lead for medication-related technology issues.


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.